We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
-0.07%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$19.1B
AUM Growth
-$4.04B
Cap. Flow
-$3.24B
Cap. Flow %
-16.98%
Top 10 Hldgs %
50.33%
Holding
204
New
48
Increased
30
Reduced
30
Closed
31

Top Buys

Rank Stock Value
1
EA
Electronic Arts
EA
+$492M
2
AVGO icon
Broadcom
AVGO
+$292M
3
KKR icon
KKR & Co
KKR
+$280M
4
ROIV icon
Roivant Sciences
ROIV
+$248M
5
MA icon
Mastercard
MA
+$138M

Top Sells

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$650M
2
CYBR
CyberArk
CYBR
+$470M
3
CRM icon
Salesforce
CRM
+$334M
4
NDAQ icon
Nasdaq
NDAQ
+$290M
5
RNAM
Avidity Biosciences
RNAM
+$233M

Sector Composition

Rank Sector Weight
1 Healthcare 46.53%
2 Communication Services 11.31%
3 Financials 11.23%
4 Technology 10.28%
5 Consumer Discretionary 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDTX
176
DELISTED
Cidara Therapeutics
CDTX
– –
-382,800
Closed -$84.6M
CRM icon
177
Salesforce
CRM
$171B
– –
-1,261,177
Closed -$334M
CYBR
178
DELISTED
CyberArk
CYBR
– –
-1,053,040
Closed -$470M
DOCS icon
179
Doximity
DOCS
$4.51B
– –
-311,000
Closed -$13.8M
EDU icon
180
New Oriental
EDU
$8.88B
– –
-196,000
Closed -$10.8M
ESTA icon
181
Establishment Labs
ESTA
$2.17B
– –
-3,000
Closed -$219K
EXAS
182
DELISTED
Exact Sciences
EXAS
– –
-6,405,000
Closed -$650M
GPCR icon
183
Structure Therapeutics
GPCR
$3.5B
– –
-454,000
Closed -$31.6M
HYG icon
184
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.8B
– –
-8,000,000
Closed -$645M
IBIT icon
185
iShares Bitcoin Trust
IBIT
$57.7B
– –
-2,137,100
Closed -$106M
ICLR icon
186
Icon
ICLR
$13.3B
– –
-1,200
Closed -$219K
INSM icon
187
CALL
Insmed
INSM
$27.5B
– –
-250,000
Closed -$43.5M
INSM icon
188
Insmed
INSM
$27.5B
– –
-3,000
Closed -$522K
LLY icon
189
PUT
Eli Lilly
LLY
$1.12T
– –
-375,000
Closed -$403M
MLYS icon
190
Mineralys Therapeutics
MLYS
$2.27B
– –
-823,296
Closed -$29.9M
NDAQ icon
191
Nasdaq
NDAQ
$54.9B
– –
-2,989,213
Closed -$290M
NYT icon
192
New York Times
NYT
$10.6B
– –
-3,280,678
Closed -$228M
RNAM
193
DELISTED
Avidity Biosciences
RNAM
– –
-3,233,000
Closed -$233M
RSP icon
194
PUT
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
– –
-3,600,000
Closed -$690M
SLNO
195
DELISTED
Soleno Therapeutics
SLNO
– –
-5,000
Closed -$232K
TRU icon
196
TransUnion
TRU
$16.2B
– –
-675,000
Closed -$57.9M
VSTM icon
197
Verastem
VSTM
$624M
– –
-2,000,000
Closed -$15.4M
DAY
198
DELISTED
Dayforce
DAY
– –
-2,925,000
Closed -$202M
ETH
199
Grayscale Ethereum Staking Mini ETF Shares
ETH
$2.03B
– –
-228,340
Closed -$6.41M
ETHA
200
iShares Ethereum Trust ETF
ETHA
$7.26B
– –
-1,481,001
Closed -$33.2M
5 6 7
8
9

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q1 2026 Portfolio in Review

As of Q1 2026, Thomas Steyer held 204 positions worth $19.1B, down 17% from $23.1B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Thomas Steyer withdrew a net $3.24B in Q1 2026, closing 31 positions and reducing 30 holdings. Its most notable exit was Exact Sciences, an estimated $650M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 41% a quarter earlier, followed by Communication Services and Financials.

Against the trend, Thomas Steyer opened a new position in Dianthus Therapeutics worth $70.2M.

  • Thomas Steyer's largest Q1 2026 buy was Dianthus Therapeutics: 836,000 shares worth $70.2M.
  • Thomas Steyer added most to Electronic Arts in Q1 2026, an estimated $492M increase.
  • Thomas Steyer's biggest Q1 2026 reduction was Wabtec, cutting an estimated $210M.
  • Thomas Steyer fully exited Exact Sciences in Q1 2026, selling an estimated $650M.
  • Thomas Steyer's ten largest holdings make up 50% of its $19.1B portfolio in Q1 2026.
  • Thomas Steyer opened 48 new positions and closed 31 in Q1 2026.
  • Thomas Steyer's portfolio value fell 17% quarter-over-quarter to $19.1B.

Based on Farallon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.